Voie dopaminergique And NotAngélique Rico
List of bibliographic references
Number of relevant bibliographic references: 29.Ident. | Authors (with country if any) | Title |
---|---|---|
000201 | Marie-Anne El Khoury [France] ; Victor Gorgievski [France] ; Larissa Moutsimilli [France] ; Bruno Giros [France, Canada] ; Eleni T. Tzavara [France] | Interactions between the cannabinoid and dopaminergic systems: Evidence from animal studies |
000947 | P. Remy [France] ; D. J. Brooks [Royaume-Uni] | La dépression dans la maladie de Parkinson : perte de l'innervation dopaminergique et noradrénergique du système limbique |
000B05 | Olga Corti [France] ; Cornelia Hampe [France] ; Frédéric Darios [France] ; Pablo Ibanez [France] ; Merle Ruberg [France] ; Alexis Brice [France] | Parkinson's disease: from causes to mechanisms |
000B31 | Thomas Debeir [France] ; Laure Ginestet [France] ; Chantal Francois [France] ; Stéphanie Laurens [France] ; Jean-Claude Martel [France] ; Philippe Chopin [France] ; Marc Marien [France] ; Francis Colpaert [France] ; Rita Raisman-Vozari [France] | Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidus |
000E43 | Christine Brefel-Courbon [France] | Maladie de Parkinson et système noradrénergique |
000F00 | Michael A. Collins [États-Unis] ; Edward J. Neafsey [États-Unis] | Potential neurotoxic "agents provocateurs" in Parkinson's disease |
000F49 | Maria-Joao Ribeiro [France] ; Marie Vidailhet [France] ; Christian Loc'H [France] ; Corinne Dupel [France] ; Jean Paul Nguyen [France] ; Michel Ponchant [France] ; Frédéric Dolle [France] ; Marc Peschanski [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Yves Samson [France] ; Philippe Remy [France] | Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease |
001084 | S. Thobois [France] ; S. Guillouet [France] ; E. Broussolle [France] | Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease |
001090 | Olivier Guillin [France] ; Jorge Diaz [France] ; Patrick Carroll [France] ; Nathalie Griffon [France] ; Jean-Charles Schwartz [France] ; Pierre Sokoloff [France] | BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization |
001093 | Thomas Poyot [France] ; Francoise Conde [France] ; Marie-Claude Gregoire [France] ; Vincent Frouin [France] ; Christine Coulon [France] ; Chantal Fuseau [France] ; Francoise Hinnen [France] ; Frédéric Dolle [France] ; Philippe Hantraye [France] ; Michel Bottlaender [France] | Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: Comparison with 6-[18f]Fluoro-L-Dopa |
001171 | E. Aliaga [Chili] ; C. Carcamo [Chili] ; J. Abarca [Chili] ; L. Tapia-Arancibia [France] ; G. Bustos [Chili] | Transient increase of brain derived neurotrophic factor mRNA expression in substantia nigra reticulata after partial lesion of the nigrostriatal dopaminergic pathway |
001188 | M. Grandbois [Canada] ; M. Morissette [Canada] ; S. Callier [Canada, France] ; T. Di Paolo [Canada] | Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice |
001204 | C. Perier [France] ; Yves Agid [France] ; E. C. Hirsch [France] ; J. Feger [France] | Ipsilateral and contralateral subthalamic activity after unilateral dopaminergic lesion |
001264 | C. Brefel-Courbon ; O. Rascol | Scintigraphies cérébrales et syndromes parkinsoniens |
001305 | G. Lucas [France] ; U. Spampinato [France] | Role of serotonin2A and serotonin2C receptor subtypes in the control of the nigro-striatal dopaminergic pathway |
001313 | A. M. Bonnet [France] ; J. L. Houeto [France] | Pathophysiology of Parkinson's disease |
001435 | P. Hantraye [France] | Modeling dopamine system dysfunction in experimental animals |
001480 | Caractérisation des mécanismes mis en jeu dans les effets de la lésion de la voie nigro-striée dopaminergique sur des populations neuronales identifiées du striatum, chez le rat. Approche morphologique combinant des techniques d'immunohistochimie et d'hybridation in situ quantitatives | |
001564 | B. Pillon [France] ; S. Ertle [France] ; B. Deweer [France] ; A.-M. Bonnet [France] ; M. Vidailhet [France] ; B. Dubois [France] | Memory for spatial location in 'de novo' parkinsonian patients |
001635 | E. Neuman [France] ; G. Rancurel [France] ; Y. Lecrubier [France] ; D. Fohanno [France] ; F. Boller [France] | Schizophreniform catatonia on 6 cases secondary to hydrocephalus with subthalamic mesencephalic tumor associated with hypodopaminergia |
001644 | M. Vila [France] ; R. Levy [France] ; M.-T. Herrero ; B. Faucheux [France] ; J. A. Obeso [France] ; Yves Agid [France] ; E. C. Hirsch | Metabolic activity of the basal ganglia in Parkinsonian syndrome in human and non-human primates : A cytochrome oxidase histochemistry study |
001676 | Fonctions exécutives: approche cognitive et métabolique dans la maladie de Parkinson | |
001731 | M. Ruberg [France] ; D. Scherman [France] ; F. Javoy-Agid [France] ; Yves Agid [France] | Dopamine denervation, age on onset, and Parkinson's disease |
001752 | Etude neuroanatomique de l'expression du récepteur dopaminergique D2 et de la préproenképhaline dans le striatum de rat après dénervation dopaminergique totale ou partielle et greffe de mésencéphale embryonnaire | |
001863 | P. Gaspar [France] ; A. Febvret [France] ; J. Colombo | Serotonergic sprouting in primate MTP-induced hemiparkinsonism |
001A20 | P. Gaspar [France] ; C. Duyckaerts [France] ; C. Alvarez ; F. Javoy-Agid ; B. Berger | Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease |
001A54 | R. Raisman-Vozari ; J.-A. Girault ; S. Moussaoui ; C. Feuerstein ; P. Jenner ; C. D. Marsden ; Yves Agid [France] | Lack of change in triatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man |
001A93 | D. Scherman ; C. Desnos ; F. Darchen ; P. Pollak ; F. Javoy-Agid ; Yves Agid [France] | Striatal dopamine deficiency in Parkinson's disease: role of aging |
001B01 | O. Rascol ; M. Clanet ; J. L. Montastruc ; M. Simonetta ; M. J. Soulier-Esteve ; B. Doyon ; A. Rascol | Abnormal ocular movements in Parkinson's disease: evidence for involvement of dopaminergic systems |
![]() | This area was generated with Dilib version V0.6.29. | ![]() |